PHASE II TRIAL OF GVHD PROPHYLAXIS WITH POST-TRANSPLANTATION CYCLOPHOSPHAMIDE FOLLOWING REDUCED-INTENSITY BUSULFAN/FLUDARABINE (BU/FLU) CONDITIONING FOR HEMATOLOGICAL MALIGNANCIES

GVHD-prophylaxis with post-transplant cyclophosphamide (CY) following ablative HLA-matched bone marrow (BM) transplantation has been reported to have comparable rates of acute GVHD with an apparent reduction in chronic GVHD and infections. We conducted a phase II trial of post-CY following reduced-i...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Biol Blood Marrow Transplant
Päätekijät: Alousi, Amin M., Brammer, Jonathan E., Saliba, Rima M., Andersson, Borje, Popat, Uday, Hosing, Chitra, Jones, Roy, Shpall, Elizabeth J, Khouri, Issa, Qazilbash, Muzaffar, Nieto, Yago, Shah, Nina, Ahmed, Sairah, Oran, Betul, Atrash, Gheath Al, Ciurea, Stefan, Kebriaei, Partow, Chen, Julianne, Rondon, Gabriela, Champlin, Richard
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 2015
Aiheet:
Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC4825327/
https://ncbi.nlm.nih.gov/pubmed/25667989
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2015.01.026
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia